Abstract |
Rifamycin B, a product of Amycolatopsis mediterranei S699, is the precursor of clinically used antibiotics that are effective against tuberculosis, leprosy, and AIDS-related mycobacterial infections. However, prolonged usage of these antibiotics has resulted in the emergence of rifamycin-resistant strains of Mycobacterium tuberculosis. As part of our effort to generate better analogs of rifamycin, we substituted the acyltransferase domain of module 6 of rifamycin polyketide synthase with that of module 2 of rapamycin polyketide synthase. The resulting mutants (rifAT6::rapAT2) of A. mediterranei S699 produced new rifamycin analogs, 24-desmethylrifamycin B and 24-desmethylrifamycin SV, which contained modification in the polyketide backbone. 24-Desmethylrifamycin B was then converted to 24-desmethylrifamycin S, whose structure was confirmed by MS, NMR, and X-ray crystallography. Subsequently, 24-desmethylrifamycin S was converted to 24-desmethylrifampicin, which showed excellent antibacterial activity against several rifampicin-resistant M. tuberculosis strains.
|
Authors | Aeshna Nigam, Khaled H Almabruk, Anjali Saxena, Jongtae Yang, Udita Mukherjee, Hardeep Kaur, Puneet Kohli, Rashmi Kumari, Priya Singh, Lev N Zakharov, Yogendra Singh, Taifo Mahmud, Rup Lal |
Journal | The Journal of biological chemistry
(J Biol Chem)
Vol. 289
Issue 30
Pg. 21142-52
(Jul 25 2014)
ISSN: 1083-351X [Electronic] United States |
PMID | 24923585
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antitubercular
- Bacterial Proteins
- Polyketide Synthases
- Acyltransferases
- Rifampin
|
Topics |
- Acyltransferases
(genetics, metabolism)
- Antibiotics, Antitubercular
(biosynthesis)
- Bacterial Proteins
(chemistry, genetics, metabolism)
- Drug Resistance, Bacterial
- Mycobacterium tuberculosis
- Polyketide Synthases
(chemistry, genetics, metabolism)
- Protein Engineering
- Rifampin
(analogs & derivatives, metabolism)
|